Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Sci Rep ; 10(1): 18509, 2020 10 28.
Artigo em Inglês | MEDLINE | ID: mdl-33116163

RESUMO

The potential therapeutic effects of molecular hydrogen (H2) have now been confirmed in various human and animal-disease models. However, the effects of H2 on the physiological function in a normal state have been largely neglected. Hydrogen-rich water (HRW) intake and hydrogen inhalation (HI) are the most common used methods for hydrogen administration, the difference in the effects between HRW intake and HI remains elusive. In the present study, the body weight and 13 serum biochemical parameters were monitored during the six-month hydrogen intervention, all these parameters were significantly altered by oral intake of HRW or HI. Among the 13 parameters, the most striking alterations induced by hydrogen treatment were observed in serum myocardial enzymes spectrum. The results also showed that the changes in these parameters occurred at different time points, and the alterations in most of the parameters were much more significant in HI than HRW. The results of this study provides the basic data for the mechanism research and application of molecular hydrogen in the future.


Assuntos
Hidrogênio/farmacologia , Ratos/fisiologia , Animais , Glicemia/efeitos dos fármacos , Peso Corporal/efeitos dos fármacos , China , Modelos Animais de Doenças , Coração/efeitos dos fármacos , Hidrogênio/administração & dosagem , Hidrogênio/metabolismo , Fígado/metabolismo , Masculino , Miocárdio/metabolismo , Estresse Oxidativo/efeitos dos fármacos , Ratos Sprague-Dawley , Triglicerídeos/análise , Ácido Úrico/análise , Ácido Úrico/sangue , Água/química
2.
Brain Res ; 1748: 147053, 2020 12 01.
Artigo em Inglês | MEDLINE | ID: mdl-32814064

RESUMO

Traumatic brain injury (TBI) is a major cause of mortality and disability worldwide. To date, therapies to treat any forms of TBI are still limited. Recent studies have demonstrated the potential neuroprotective effects of molecular hydrogen on TBI. Although it has been demonstrated that hydrogen inhalation (HI) for about 5 hrs immediately after TBI has a beneficial effect on brain injury, the most effective intervention procedure in the treatment of TBI remains unknown. The mechanism underlying the neuroprotective effects of HI on TBI also needs to be further investigated. Our results showed that inhalation of 4% hydrogen during the first day after TBI was the most effective hydrogen intervention procedure in the treatment of TBI. Pathological examination showed that HI could attenuate TBI-induced reactive astrocytosis and microglial activation. Nissl staining demonstrated a significant decrease in the number of nissl-stained dark neurons (N-DNs) in HI group compared to TBI group at 2 h post-TBI, and the TBI-induced neuronal loss was attenuated by HI at day 3 post-TBI. IHC staining showed that HI resulted a decrease in CD16-positive cells and a further increase in CD206-positive cells as compared to TBI group. Multiplex cytokine assay demonstrated the most profound regulatory effects induced by HI on the levels of IL-12, IFN-γ, and GM-CSF at 24 h post-TBI, which confirmed the inhibitory effect of hydrogen on microglia activation. We concluded that inhalation of 4% hydrogen during the first day after TBI was the most effective intervention procedure in the treatment of TBI. Our results also showed that hydrogen may exert its protective effects on TBI via inhibition of microglia activation and neuroinflammation.


Assuntos
Lesões Encefálicas Traumáticas/metabolismo , Encéfalo/efeitos dos fármacos , Hidrogênio/farmacologia , Inflamação/metabolismo , Microglia/efeitos dos fármacos , Fármacos Neuroprotetores/farmacologia , Animais , Encéfalo/metabolismo , Encéfalo/patologia , Lesões Encefálicas Traumáticas/tratamento farmacológico , Lesões Encefálicas Traumáticas/patologia , Modelos Animais de Doenças , Hidrogênio/uso terapêutico , Inflamação/tratamento farmacológico , Inflamação/patologia , Masculino , Microglia/metabolismo , Neurônios/efeitos dos fármacos , Neurônios/metabolismo , Neurônios/patologia , Fármacos Neuroprotetores/uso terapêutico , Ratos , Ratos Sprague-Dawley , Transdução de Sinais/efeitos dos fármacos
3.
Cell Death Dis ; 9(5): 575, 2018 05 01.
Artigo em Inglês | MEDLINE | ID: mdl-29760381

RESUMO

It is well known that induction of hepatocyte senescence could inhibit the development of hepatocellular carcinoma (HCC). Until now, it is still unclear how the degree of liver injury dictates hepatocyte senescence and carcinogenesis. In this study, we investigated whether the severity of injury determines cell fate decisions between hepatocyte senescence and carcinogenesis. After testing of different degrees of liver injury, we found that hepatocyte senescence is strongly induced in the setting of severe acute liver injury. Longer-term, moderate liver injury, on the contrary did not result into hepatocyte senescence, but led to a significant incidence of HCC instead. In addition, carcinogenesis was significantly reduced by the induction of severe acute injury after chronic moderate liver injury. Meanwhile, immune surveillance, especially the activations of macrophages, was activated after re-induction of senescence by severe acute liver injury. We conclude that severe acute liver injury leads to hepatocyte senescence along with activating immune surveillance and a low incidence of HCC, whereas chronic moderate injury allows hepatocytes to proliferate rather than to enter into senescence, and correlates with a high incidence of HCC. This study improves our understanding in hepatocyte cell fate decisions and suggests a potential clinical strategy to induce senescence to treat HCC.


Assuntos
Carcinoma Hepatocelular/metabolismo , Senescência Celular , Hepatócitos/metabolismo , Neoplasias Hepáticas/metabolismo , Fígado/lesões , Fígado/metabolismo , Doença Aguda , Animais , Carcinoma Hepatocelular/patologia , Hepatócitos/patologia , Fígado/patologia , Neoplasias Hepáticas/patologia , Camundongos , Camundongos Knockout
4.
Di Yi Jun Yi Da Xue Xue Bao ; 22(7): 650-2, 2002 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-12376303

RESUMO

OBJECTIVE: To compare the differences in glycyrrhizic acid contents of Gegenqinlian decoctions (a traditional Chinese herbal preparation) prepared according to varied prescription, so as to establish a referential standard for controlling the acid level in such preparations. METHODS: Reverse phase-high performance liquid chromatography (RP-HPLC) was employed to determine the content of glycyrrhizic acid in different Gegenqinlian decoctions. RESULTS: Glycyrrhizic acid contents in the decoction of exclusive liquorice was 0.89%, and in Gegenqinlian decoctions composed of 2 or 3 ingredients, the acid contents varied from 0.24%, to 0.59%,. CONCLUSION: The presence of the constituents in Gegenqinlian decoction such as radices puerarire, radices scutellariae and coptis may significantly reduce the release of glycyrrhizic acid content from within liquorice into the decoction.


Assuntos
Medicamentos de Ervas Chinesas/química , Ácido Glicirrízico/análise , Medicina Tradicional Chinesa , Padrões de Referência
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA